|
Quotes & Info
|
| ADLI.OB > SEC Filings for ADLI.OB > Form 8-K on 20-Feb-2009 | All Recent SEC Filings |
20-Feb-2009
Change in Directors or Principal Officers, Financial Stateme
Change in President/Chief Executive Officer
Judd D. Hoffman, the Chief Executive Officer and President of American Medical Technologies, Inc. (the "Company"), has resigned from those positions effective on February 17, 2009. Mr. Hoffman will remain as a director and Chairman of the Board of Directors of the Company.
The Board of Directors appointed Jeffrey Goodman to serve as the Chief Executive
Officer and President of the Company effective February 23, 2009, to fill the
vacancy left by Mr. Hoffman's departure. Jeffrey Goodman, age 53, founded
Corestrength, Inc., a management consulting company, in 2003 and has served as
the Chief Executive Officer of Corestrength, Inc. since August 2003. Form
October 2000 to June 2003, Mr. Goodman served as President of Dent-X in
Elmsford, New York. From March 2998 to August 2000, Mr. Goodman served as Chief
Executive Officer and President of Dexpo.com in Pennsylvania. Mr. Goodman has
broad experience in dental manufacturing and distribution, having also served as
the President of ESPE America, and the Director of Marketing of Benco Dental.
In addition to his experience in the dental industry, Jeffrey founded,
developed and sold Business Technology Group, a distribution-oriented software
developer. He received a B.A. in Accounting and Economics from Muhlenberg
College in 1977, and an MBA in Finance from Northeastern University in 1981.
Mr. Goodman has been appointed to the Board of Directors of the Company effective February 23, 2009.
The Company entered into a consulting agreement with Corestrength, Inc., a Florida Corporation which agreed to provide the services of Jeffrey Goodman. The Company has retained Mr. Goodman as Chief Executive Officer and as a director. The consulting agreement will commence on February 23, 2009 with an initial period ending May 31, 2009. After the conclusion of the initial period, the Company has the right to renew the contract for an additional three month term. In the event the contract is not extended for an additional three month term, and/or after such extension, the contract will automatically renew for additional monthly periods, unless either party provides ten (10) days written notice of their intention to terminate the agreement. In consideration for Mr. Goodman's service to the Company, the Company will pay a monthly fee of $12,000 to Corestrength, Inc. of which Mr. Goodman is a beneficial owner.
Corestrength, Inc. provides domestic and Canadian sales representation services for Spectrum Dental products, which the Company has an exclusive worldwide license to distribute and receives $3,000 per month plus 13.5% of any Spectrum sales in consideration for such sales representation services.
Exhibit Description of Exhibit
10.1* Consulting Agreement between American Medical Technologies, Inc. and Corestrength, Inc.
* Filed herewith.
|
|